Emerging Technologies: New Antibody-Based Technologies

Share the joy

New English word? Translate any word using double click.

Article by Jennifer1661.

Emerging Technologies: new antibody-based Technologies – Health.

( Search by author, title or content,Title Article NameArticle ContentAuthorMaisonSoumettre of articlesLignes guidelines AuteurLignes guidelines EditeurDes flow contenuFlux RSSFAQContactez-nousPrésentation ).

The market for therapeutic monoclonal antibodies, the fastest growing industry sector, type of molecule, is expected to maintain growth impressive until 2016. In this market a new class of therapies will become increasingly important over the next six years, to be presented in the report. In addition, major companies and pipeline candidates for each technology will be profiled.

Features & Benefits :

Instructions will identify prospects in the sector through the next 6 years , Analyze pipeline candidates each of these technologies to the respective companies involved key, Facts Highlights, Six new antibody-based technologies will be presented with the key players for each technology profiles and full assessment of the pipeline of technology (from preclinical to late stage) will be provided. Finally, market expectations for this emerging sector will be compared with the prescription pharmaceutical market as a whole,Table of Contents, Emerging Technologies, New antibody-based technology.

ABOUT THIS REPORT ;

PharmaVitae Explorer, database Chapter, structure Biologic, technology market and the key dynamics of The players Product profiles Data consensus sourcing Analyst.

CONTENTS ;

Key findings Introducing the new antibody-based products in developing new business landscape technologies, The antibody-based technologies, The leading technology driving new antibody-based technology and development New commercial return on 2010-16The mAb market will continue to be the fastest growing sector in the pharmaceutical industry as a whole.

Biology, MARKET DYNAMICS, Findings Introduction and key company performance PharmaVitae universe of The prescription pharmaceutical market, 2010-16Prescription performance pharmaceutical market, 2010-16Biologics led growth, 2010-16Introduction market analysis Prescription molecule pharmaceutical type, type of molecule, 2004 – 16The mAb market will continue to be the most dynamic sector across the entire pharmaceutical industry New to technologies Antibody-based drug conjugates will be the key factor in an emerging class.

TECHNOLOGY AND KEY PLAYERS ;

Findings Overview: key emerging antibody-based weaning-to technologies, Antibody conjugates My lotarg was a market Oncology blow to the ADC is the liveliest area of ??ADC keys antibodies development ADC players Seattle GeneticsImmunoGenBispecific and trifunctional (Untitled sub-section) antibodiesDomain trifunctional antibodies and antibodies nanobodiesDomain: GSK – through Domantis – led to the fieldAblynx nanobodiesFc- antibody engineering.

PRODUCT PROFILES (RemovabAdcetrisTrastuzumab emtansineInotuzumab ozogamicinGA101/RG-7159), SCHEDULE researchExchange ReferencesDatamonitor rate.

TABLES ;

Table: Number of candidates for pipelines, by company, 2011Table: New technology market antibody-based launches, 2010-16Table: market sales MAB, by technology ($ m), 2010-16Table: PharmaVitae company coverage by peer setTable: definitionsTable type of molecule: general characteristics of small molecule drugs against biologicsTable: sales of prescription pharmaceuticals, according to the molecule type ($ m), 2010-16Table : market sales MAB, by technology ($ m), 2010-16Table: Emerging technologies overview, 2011Table: Number of technology development stage, 2011Table: Antibody Drug Conjugate candidatesTable: candidatesTable and trifunctional bispecific antibody: antibody domain and candidatesTable Nanobodies: antibody-drug conjugates candidatesTable: Removab: overviewTable: Adcetris: overviewTable: trastuzumab emtansine: overviewTable: gemtuzumab inotuzumab: overviewTable: GA101/RG-7159: overviewTable: Exchange rates, 2011 .

LIST OF FIGURES ;

Figure: The ExplorerFigure PharmaVitae: New antibody-based, preclinical technologies approved 2011Figure: The total market sales MAb ($ m and%), 2004-16Figure: Proportion of sales market new technologies mAb antibody-based (%), 2004-16Figure: The total pharmaceutical market outlook, sales ($ M) and the growth rate from year to year (%), 2004-16Figure: Total sales of prescription pharmaceutical market ($ m), 2004-16Figure: total sales growth of prescription pharmaceutical market, according to the type of molecule ($ bn), 2004-16Figure: The total market sales MAb (m $ and%), 2004-16Figure: market sales MAB, by technology ($ m), 2004-16Figure: Number of technology development stage, 2011. Browse the medical device market research .

ReportsnReports :

Is an online library of over 100,000 + market research reports and in-depth market research and market analysis of over 5000 micro. We provide 24/7 support online and offline for our clients. Get in touch with us for your reporting needs of market research .

Contact :

Mr.Priyank7557 Rambler Road, Suite727, Dallas, TX75231Tel: + 5441 1888391 E-mail: sales of ‘affaires@reportsandreports.com .

About the AuteurReportsnReports :

Is an online library of reports + of over 100,000 market research and in-depth market research and analysis of over 5000 micro markets. We provide 24/7 support online and offline for our clients. Get in touch with us for your reporting needs of market research .

Follow us on Twitter: http://twitter.com/marketsreports our Facebook page: http://www.facebook.com/pages/ ReportsnReports / 191441427571689 – E-mail: sales@reportsnreports.com and http :// www.reportsnreports.com – Visit our Blog Market ResearchUtilisation .

Use and distribution of this article is subject to our guidelines (Editeurpar) which information of the original author and copyright must be included.

Jennifer1661

RSS RSSL’article SignalerPublier the articleImprimer the articleAjouter to FavorisAnnuaire.articleSurFAQContactez-nousRecherche avancéeDéclaration of confidentialitéDésistement.
GoArticles.com © 2012, All rights reserved.



Your Comment is Valuable, Social Comment For Free &
One Advertising Comment For .5$ Only !
Note: 10 Websites in one comment as Maximum, Please Write Your
Site Name At Your Guest Name Box At Comments Fill out That Matches
the One in The Descriptions Of Your Order Summary. Kindly, No Porn,
No Alcohol Related, No Gambling, Neither Does Sindybakur.com Nor
Its Employees Accept Religious or Political related Comments.
Further, Comment will appear for One Month. Please be
informed that Any Violation Of These Rules Would
Result In Funds Disclaim and Comment
Deletion, Good Luck & Thank You .




More Than One Ad Comment OR Donation to
Stimulate this Site’s Staff, Thank You .




Share the joy

Comments

  1. I needed to thank you for this excellent read!! I definitely loved every bit of it. I’ve got you bookmarked to look at new stuff you post…

  2. which car seat says:

    Nice post. I learn something new and challenging on sites I stumbleupon on a daily basis. It will always be helpful to read through content from other writers and practice something from their web sites.